FDA 's and EMA 's approval of brentuximab vedotin for advanced Hodgkin lymphoma: another player in the town?
Milunović, Vibor, Mišura Jakobac, Karla, Kursar, Marin, Mandac Rogulj, Inga, Ostojić Kolonić, SlobodankaLanguage:
english
Journal:
European Journal of Haematology
DOI:
10.1111/ejh.13269
Date:
June, 2019
File:
PDF, 341 KB
english, 2019